Investigación clínica por ciudad y condición

Ensayos clínicos de obesidad en Monterrey

Estudios relacionados con obesidad, control de peso y condiciones metabólicas asociadas. Cada protocolo define criterios específicos de edad, IMC, tratamientos y comorbilidades.

Estudios detectados14
Sedes identificables15
CiudadMonterrey
Revisión2026-09-26
Alcance: estos conteos reflejan registros Recruiting o Not Yet Recruiting con al menos una sede declarada en la ciudad. No sustituyen COFEPRIS/RNEC ni confirman disponibilidad inmediata de cupo.

Estudios registrados

ReclutandoNCT06937086

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Fase 3Eli Lilly and Company

Condiciones: Ulcerative Colitis, Obesity or Overweight

Sedes en Monterrey: Servicios de Oncología Médica Integral - Monterrey

Ver registro oficial ↗
ReclutandoNCT06937099

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Fase 3Eli Lilly and Company

Condiciones: Crohn's Disease, Obesity or Overweight

Sedes en Monterrey: Servicios de Oncología Médica Integral - Monterrey

Ver registro oficial ↗
ReclutandoNCT07037433

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Fase 3Amgen

Condiciones: Atherosclerotic Cardiovascular Disease, Overweight, Obesity

Sedes en Monterrey: Cardiolink Clin Trials · Unidad Biomedica Avanzada Monterrey

Ver registro oficial ↗
ReclutandoNCT07567001

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Fase 3Novo Nordisk A/S

Condiciones: Obesity, Heart Failure

Sedes en Monterrey: Internal Medicine Clin Trials · Hospital Universitario Dr. José Eleuterio González_Monterrey · Hospital Zambrano Hellion TecSalud

Ver ficha informativa
ReclutandoNCT07794579

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Fase 3Eli Lilly and Company

Condiciones: Overweight, Prediabetic State, Prehypertension

Sedes en Monterrey: Centro de investigación y control metabólico

Ver registro oficial ↗
ReclutandoNCT07037459

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Fase 3Amgen

Condiciones: Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity

Sedes en Monterrey: Cardiolink Clin Trials

Ver registro oficial ↗
ReclutandoNCT07392190

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Fase 3Eli Lilly and Company

Condiciones: Overweight, Obesity

Sedes en Monterrey: CEINV Salud · Clínica García Flores SC

Ver registro oficial ↗
ReclutandoNCT06439277

A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)

Fase 3Eli Lilly and Company

Condiciones: Obesity, Weight Gain

Sedes en Monterrey: Christus - Latam Hub Center of Excellence and Innovation S.C. · Clínica García Flores SC

Ver registro oficial ↗
ReclutandoNCT07282600

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Fase 3Eli Lilly and Company

Condiciones: Overweight, Obesity

Sedes en Monterrey: Cardiolink Clin Trials

Ver registro oficial ↗
ReclutandoNCT07253285

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Fase 3Novo Nordisk A/S

Condiciones: Overweight, Obesity

Sedes en Monterrey: CHRISTUS - Latam Hub Excellence and Innovation Center · IECSI Centro de Investigación Clínica

Ver registro oficial ↗